Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Prolonged hypocalcemia following denosumab therapy in metastatic hormone refractory prostate cancer
Author: Milat, F.
Goh, S.
Gani, L.
Suriadi, C.
Gillespie, M.
Fuller, P.
Teede, H.
Strickland, A.
Allan, C.
Citation: Bone, 2013; 55(2):305-308
Publisher: Elsevier
Issue Date: 2013
ISSN: 8756-3282
Statement of
F. Milat, S. Goh, L.U. Gani, C. Suriadi, M.T. Gillespie, P.J. Fuller, H.J. Teede, A.H. Strickland, C.A. Allan
Abstract: Prostate cancer is a leading cause of cancer death, frequently associated with widespread bone metastases. We report two cases of hypocalcemia following the first dose of denosumab in metastatic hormone refractory prostate cancer, the first case requiring 26 days of intravenous calcium therapy. This is the first report of prolonged hypocalcemia following denosumab in a patient with normal renal function.
Keywords: Prostate cancer; bone; denosumab; hypocalcemia
Rights: Crown Copyright © 2013 Published by Elsevier Inc. All rights reserved.
RMID: 0030094787
DOI: 10.1016/j.bone.2013.04.012
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.